Psychiatric morbidity in children and adolescents with dermatological disorders

Sociodemographic characteristics		Study N (%)	Control N (%)	X^2*	p
Gender	Male Female	93 (37.1) 158 (62.9)	111 (44.2) 140 (55.8)	2.67	0.102
Residential place	City Rural Area (Village + Town)	182 (72.5) 69 (27.5)	226 (90) 25 (10)	25.34	0.0001
School success	Successful Struggling	175 (72.9) 65 (27.1)	200 (81) 47 (19)	4.46	0.035
Family type	Nuclear Extended	184 (73.3) 67 (26.7)	214 (85.3) 37 (14.7)	10.91	0.0001
Psychiatric disease history in the family	Exists Does not exist	30 (12) 221 (88)	23 (9.2) 228 (90.8)	1.03	0.309
Togetherness with both parents	Exists Does not exist	229 (91.2) 22 (8.8)	232 (92.4) 19 (7.6)	0.23	0.625
			X±SS	t**	p
Age (6-18 years)		12.63±4.16	12.73±4.06	0.28	0.778
Number of siblings		2.46±1.77	2.08±1.53	2.55	0.011

1 Note. *Chi-square test, Chi-square value; ** Unpaired t test-value

TABLE 2.

Diagnostic distributions of dermatological diseases

Dermatological disease	n	%
Inflammatory dermatoses	55	21.9
Eczematous and allergic dermatoses	43	17.1
Acneiform dermatoses	42	16.7
Hair and nail disorders	36	14.3
Chronic infectious dermatoses	32	12.7
Pigmentation disorders	24	9.6
Others (chronic cutaneous disorders)	10	4.0
Others (acute/transient conditions)	6	2.4
Genetic dermatoses	3	1.2
Total	251	100

TABLE 3.

Comparison of psychiatric diagnosis distributions

K-SADS-PL and DSM-IV Diagnoses		Study N (%)	Control N (%)	X²	p
Psychiatric Disorder	Exists Does not Exist	145 (57.8) 106 (42.2)	84 (33.5) 167 (66.5)	29.8	0.0001
ADHD	Exists Does not Exist	57 (22.7) 194 (77.3)	49 (19.5) 202 (80.5)	0.76	0.382
Disruptive behavior disorders	Exist Do not exist	9 (3.6) 242 (96.4)	6 (2.4) 245 (97.6)	0.61	0.432
Mood disorders	Exist Do not Exist	35 (13.9) 216 (86.1)	13 (5.2) 238 (94.8)	11.14	0.001
Anxiety disorders	Exist Do not Exist	37 (14.7) 214 (85.3)	14 (5.6) 237 (94.4)	11.54	0.001
Psychotic disorder	Exists Does not Exist	1 (0.4) 250 (96.6)	- 251 (100)	1.00	0.317
Speech disorder	Exists Does not Exist	2 (0.8) 249 (99.2)	3 (1.2) 248 (98.8)	0.20	0.653
Tic disorders	Exist Do not Exist	4 (1.6) 247 (98.4)	2 (0.8) 249 (99.2)	0.67	0.411
Adjustment disorder	Exists Does not Exist	29 (11.6) 222 (88.4)	251 (100)	30.77	0.0001
Elimination disorders	Exist Do not Exist	13 (5.2) 238 (94.8)	11 (4.4) 240 (95.6)	0.17	0.676
Somatoform disorders	Exist Do not exist	1 (0.4) 250 (99.6)	1 (0.4) 250 (99.6)	0.00	1.00
Trichotillomania	Exists Does not Exist	1 (0.4) 250 (99.6)	251 (100)	1.00	0.317
Tobacco use	Exists Does not Exist	4 (1.6) 247 (98.4)	6 (2.4) 245 (97.6)	0.40	0.523
Sleep disorders	Exist Do not Exist	4 (1.6) 247 (98.4)	251 (100)	4.03	0.124

1 Note. *Pearson Chi Square test

TABLE 4.

Comparison of inventory scores

INVENTORY		STUDY	CONTROL
INVENTORY		Median (Min-Max)	Median (Min-Max)	P*
Depression		9 (0-39)	6 (0-35)	0.0001
STAI-1		35 (20-71)	31(20-73)	0.0001
STAI-2		45 (17-78)	41 (25-80)	0.0001
SDQ-P	Total difficulty score	11 (0-28)	9 (1-31)	0.0001
	Emotional problems	3 (0-10)	2 (0-9)	0.0001
	Behavior problems	2 (0-7)	1 (0-8)	0.001
	Attention and activity problems	4 (0-10)	3 (0-10)	0.002
	Peer problems	3 (0-10)	2 (0-8)	0.0001
	Social behaviors	8(1-10)	9 (2-10)	0.009
SDQ-A	Total difficulty score	11(1-29)	9 (0-30)	0.0001
	Emotional problems	3(0-10)	2 (0-10)	0.001
	Behavior problems	1(0-7)	1 (0-8)	0.039
	Attention and activity problems	4 (0-9)	3.5 (0-10)	0.007
	Peer problems	3 (0-10)	2 (0-8)	0.001
	Social behaviors	9 (2-10)	9 (1-10)	0.064

1 Note. * Mann-Whitney’s U test

TABLE 5.

Psychiatric comorbidity frequency in dermatological disease sub-groups

Dermatological disease sub-groups	Psychiatric comorbidity (n=145)	No-psychiatric comorbidity (n=106)	X²	p^*
Inflammatory dermatoses	24 (16.6)	31(29.2)	5.76	0.016
Eczematous and allergic dermatoses	31 (21.4)	12 (11.3)	4.36	0.037
Acneiform dermatoses	25 (17.2)	17 (16.0)	0.06	0.801
Hair and nail disorders	24 (16.6)	12 (11.3)	1.36	0.243
Chronic infectious dermatoses	19 (13.1)	13 (12.3)	0.03	0.844
Pigmentation disorders	13 (9.0)	11(10.4)	0.14	0.707
Others (chronic cutaneous disorders)	7 (4.8)	5 (4.7)	0.63	0.525
Others (acute/transient conditions)	1 (0.7)	5 (4.7)	4.25	0.086
Genetic dermatoses	1 (0.7)	2 (1.9)	0.74	0.575

1 Note. *Pearson Chi Square test

TABLE 6.

Frequency of psychiatric comorbidity incidence according to certain clinical features of dermatological diseases

Clinical Features	Psychiatric comorbidity (n=145)	No-psychiatric comorbidity (n=106)	X²	p
Restrictedness in physical activity	26 (17.9)	7 (6.6)	6.88	0.009
Chronicity	116 (80)	89 (84)	0.64	0.423
Having a relapsing course	89 (61.4)	64 (60.4)	0.026	0.872
Painfulness	10 (6.9)	11 (10.4)	0.96	0.325
Itchiness	51 (35.2)	29 (27.4)	1.72	0.189
Localization in visible place	94 (64.8)	66 (62.3)	0.17	0.676
Being systemic	21 (14.5)	17 (16)	0.11	0.734

1 Note. *Pearson Chi Square test

References

Authors

Metrics

Articles in this issue

DOI: https://doi.org/10.21307/sjcapp-2021-001 | Journal eISSN: 2245-8875

Journal RSS Feed

Language: English

Page range: 1 - 8

Published online: Jan 29, 2021

Published in print: Jan 1, 2021

Published by: Center for Evidence-based Psychiatry

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

Dermatological diseases,

psychiatric disorders,

and children and adolescents

Related subjects:

Medicine,

Basic medical science,

Basic medical science, other

© 2021 Dilşad Yıldız Miniksar, Özlem Özel Özcan, Hülya Cenk, Yelda Kapıcıoğlu, Ayşegül Polat, published by Center for Evidence-based Psychiatry
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 9 (2021): Issue 1 (January 2021)